G.C. Yathish, MD, is a second-year rheumatology DNB student at Hinduja Hospital in Mumbai, India.
Taral Parikh, MD, is a third-year rheumatology DNB student at Hinduja Hospital in Mumbai, India.
Parikshit Sagdeo, MD, is a first-year rheumatology DNB student at Hinduja Hospital in Mumbai, India.
Balakrishnan Canchi, MD, is the chief of rheumatology at Hinduja Hospital in Mumbai, India.
Gurmeet Mangat, MD, is a consultant rheumatologist at Hinduja Hospital in Mumbai, India.
Why Rheumatologists Need to Know about Melioidosis
- It’s common in an immunocompromised host, so many of our patients are at risk;
- It can present as septic arthritis;
- The number of cases appears to be increasing in Southeast Asia and Africa;
- A handful of cases are reported yearly in the U.S., mainly among travelers and immigrants; and
- B. pseudomallei is considered a Group B bioterrorism agent.
- Raja NS, Ahmed MZ, Singh NN. Melioidosis: An emerging infectious disease. J Postgrad Med. 2005 Apr–Jun;51(2):140–145.
- White NJ. Melioidosis. Lancet. 2003 May 17;361(9370):1715–1722.
- Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: A 10-year prospective study and review of the literature. Clin Infect Dis. 2000 Oct;31(4):981–986.
- Kosuwon W, Taimglang T, Sirichativapee W, et al. Melioidotic septic arthritis and its risk factors. J Bone Joint Surg Am. 2003 Jun;85-A(6):1058–1061.
- Jesudason MV, Anbarasu A, John TJ. Septicaemic melioidosis in a tertiary care hospital in south India. Indian J Med Res. 2003 Mar;117:119–121.
- Hoque SN, Minassian M, Clipstone S, et al. Melioidosis presenting as septic arthritis in Bengali men in east London. Rheumatology (Oxford). 1999;38(10):1029–1031.